Stock UTHR UNITED THERAPEUTICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Other languages United Therapeutics Corporation

Equities

UTHR

US91307C1027

Real-time Estimate Cboe BZX
Other stock markets
 03:05:03 2024-05-28 pm EDT 		5-day change 1st Jan Change
268.6 USD -1.58% Intraday chart for United Therapeutics Corporation -2.50% +22.02%
May. 16 United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing MT
May. 14 United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,911,532, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,898,393, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $949,737, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,871,233, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $2,585,601, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $582,195, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,829,903, According to a Recent SEC Filing
United Therapeutics Q1 Net Income, Revenue Advance; Shares Rise Pre-Bell
United Therapeutics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. UTHR Stock
  4. News United Therapeutics Corporation
  5. Other languages